RadiSys
What analysts say:
- Buy, sell, or hold?: Analysts are very bullish on this stock, unanimously backing it as a buy. That rating hasn't budged in three months as analysts have remained unchanged in their opinion of the stock.
- Revenue forecasts: On average, analysts predict $77.1 million in revenue this quarter. That would represent a rise of 4.8% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is a loss of $0.03 per share.
What our community says:
CAPS All-Stars are strongly backing the stock, with 87.1% assigning it an outperform rating. The greater community is in line with the All-Stars, as 91.2% give it a rating of outperform. Even with a robust four out of five stars, RadiSys' CAPS rating falls a little short of the community's upbeat outlook.
Management:
Revenue has now gone up for three straight quarters.
Quarter | Q4 | Q3 | Q2 | Q1 |
Gross Margin | 31.2% | 28.6% | 29.8% | 27.5% |
Operating Margin | (8.1%) | (5.6%) | 0.8% | (0.1%) |
Net Margin | (8.4%) | 2.8% | 0.2% | (0.7%) |
For all our RadiSys-specific analysis, including earnings and beyond, add RadiSys to My Watchlist.
The Motley Fool has a disclosure policy. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Earnings estimates provided by Zacks.